<SEC-DOCUMENT>0001493152-24-019449.txt : 20240515
<SEC-HEADER>0001493152-24-019449.hdr.sgml : 20240515
<ACCEPTANCE-DATETIME>20240515073033
ACCESSION NUMBER:		0001493152-24-019449
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20240515
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240515
DATE AS OF CHANGE:		20240515

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ABEONA THERAPEUTICS INC.
		CENTRAL INDEX KEY:			0000318306
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				830221517
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15771
		FILM NUMBER:		24947153

	BUSINESS ADDRESS:	
		STREET 1:		6555 CARNEGIE AVE, 4TH FLOOR
		CITY:			CLEVELAND
		STATE:			OH
		ZIP:			44103
		BUSINESS PHONE:		646-813-4701

	MAIL ADDRESS:	
		STREET 1:		6555 CARNEGIE AVE, 4TH FLOOR
		CITY:			CLEVELAND
		STATE:			OH
		ZIP:			44103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PLASMATECH BIOPHARMACEUTICALS INC
		DATE OF NAME CHANGE:	20140922

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ACCESS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19960209

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHEMEX PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:ABEO="http://abeonatherapeutics.com/20240515">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_033_ABEO_abeonatherapeutics.com_20240515 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20240515_20240515 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0000318306 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-05-15" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-05-15" id="Fact000004" name="dei:EntityCentralIndexKey">0000318306</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="abeo-20240515.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-05-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000318306</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-15</xbrli:startDate>
        <xbrli:endDate>2024-05-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
DC 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_905_edei--DocumentType_c20240515__20240515_zMaa0Uvltdll"><ix:nonNumeric contextRef="AsOf2024-05-15" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PURSUANT
TO SECTION 13 OR 15(d) OF THE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITIES
EXCHANGE ACT OF 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of report (Date of earliest event reported): <b><span id="xdx_905_edei--DocumentPeriodEndDate_c20240515__20240515_zIelmr6fXuka"><ix:nonNumeric contextRef="AsOf2024-05-15" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">May 15, 2024</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span style="text-decoration: underline"><span id="xdx_90D_edei--EntityRegistrantName_c20240515__20240515_zzbGPh1xOEol"><ix:nonNumeric contextRef="AsOf2024-05-15" id="Fact000011" name="dei:EntityRegistrantName">ABEONA
THERAPEUTICS INC.</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityIncorporationStateCountryCode_c20240515__20240515_zg6qJ0B7UFI4"><ix:nonNumeric contextRef="AsOf2024-05-15" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityFileNumber_c20240515__20240515_zcgK2GbnCMif"><ix:nonNumeric contextRef="AsOf2024-05-15" id="Fact000013" name="dei:EntityFileNumber">001-15771</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--EntityTaxIdentificationNumber_c20240515__20240515_zqZ7ukIhJZBc"><ix:nonNumeric contextRef="AsOf2024-05-15" id="Fact000014" name="dei:EntityTaxIdentificationNumber">83-0221517</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Tims New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction</span></p>
                                                                             <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of incorporation)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityAddressAddressLine1_c20240515__20240515_zaZpkTlDkIkl"><ix:nonNumeric contextRef="AsOf2024-05-15" id="Fact000015" name="dei:EntityAddressAddressLine1">6555
Carnegie Ave</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressAddressLine2_c20240515__20240515_zQHWSTkaJp1g"><ix:nonNumeric contextRef="AsOf2024-05-15" id="Fact000016" name="dei:EntityAddressAddressLine2">4th Floor</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90A_edei--EntityAddressCityOrTown_c20240515__20240515_z0UP8fSgrS75"><ix:nonNumeric contextRef="AsOf2024-05-15" id="Fact000017" name="dei:EntityAddressCityOrTown">Cleveland</ix:nonNumeric></span>,
<span id="xdx_907_edei--EntityAddressStateOrProvince_c20240515__20240515_zHNhtuB7vrPh"><ix:nonNumeric contextRef="AsOf2024-05-15" id="Fact000018" name="dei:EntityAddressStateOrProvince">OH</ix:nonNumeric></span> <span id="xdx_909_edei--EntityAddressPostalZipCode_c20240515__20240515_zMkzTqSwiJC7"><ix:nonNumeric contextRef="AsOf2024-05-15" id="Fact000019" name="dei:EntityAddressPostalZipCode">44103</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>(Address
of principal executive offices) (Zip Code)</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">(<span id="xdx_908_edei--CityAreaCode_c20240515__20240515_zGxJMLdaDyKb"><ix:nonNumeric contextRef="AsOf2024-05-15" id="Fact000020" name="dei:CityAreaCode">646</ix:nonNumeric></span>)
<span id="xdx_906_edei--LocalPhoneNumber_c20240515__20240515_zY8kvbF2gih9"><ix:nonNumeric contextRef="AsOf2024-05-15" id="Fact000021" name="dei:LocalPhoneNumber">813-4701</ix:nonNumeric></span><br/>
</span></b>(Registrant&#8217;s telephone number, including area code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">N/A</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--WrittenCommunications_c20240515__20240515_ze9EQFeLQWs4"><ix:nonNumeric contextRef="AsOf2024-05-15" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--SolicitingMaterial_c20240515__20240515_zN0EsFyzdJK1"><ix:nonNumeric contextRef="AsOf2024-05-15" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--PreCommencementTenderOffer_c20240515__20240515_zlYAPkt9VaPi"><ix:nonNumeric contextRef="AsOf2024-05-15" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--PreCommencementIssuerTenderOffer_c20240515__20240515_z0jyuoxIlHpi"><ix:nonNumeric contextRef="AsOf2024-05-15" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Each Class</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--Security12bTitle_c20240515__20240515_zpSYbTBZ8c94"><ix:nonNumeric contextRef="AsOf2024-05-15" id="Fact000026" name="dei:Security12bTitle">Common
    Stock, $0.01 par value</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--TradingSymbol_c20240515__20240515_zi1Chd0wB8pg"><ix:nonNumeric contextRef="AsOf2024-05-15" id="Fact000027" name="dei:TradingSymbol">ABEO</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span><span id="xdx_90A_edei--SecurityExchangeName_c20240515__20240515_z4UH2aakvyIj"><ix:nonNumeric contextRef="AsOf2024-05-15" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span>
    Capital Markets</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_906_edei--EntityEmergingGrowthCompany_c20240515__20240515_zC61sAFS9XGa"><ix:nonNumeric contextRef="AsOf2024-05-15" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
2.02. Results of Operations and Financial Condition.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 15, 2024, Abeona Therapeutics Inc. issued a press release entitled &#8220;Abeona Therapeutics Reports First Quarter 2024 Financial
Results and Recent Corporate Progress&#8221; regarding its financial results for the quarter ended March 31, 2024. The full text of the
press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed &#8220;filed&#8221;
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject
to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933,
as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01 Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press release, dated May 15, 2024, entitled &#8220;Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress&#8221;</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abeona
    Therapeutics Inc.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Joseph Vazzano</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph
    Vazzano</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
May 15, 2024</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjU0KwkAMhU/QO4RZS38G66JLi4pYpZQibkcbZbCdlMz4dyRv6dgihkAI733vCTERK1rqFhkO86qAGru+VQ6hwjMymhN6R77eZOBvhRdtHSvjhvcH5uQZ9EwaSnn0wmC9a4tNBnEaJdNITiGWWTqDciuCr56TOesGjdOqBWUaKJl61ugUv8aEWj3JUPcaqvbIVpPJIAnjUX6DjBMJO7qrB/HVQlHkIpgME4gV0633rsXTofmSsGix83V2pP8bfAAIpEqQ -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-1_001.jpg" ALT="" STYLE="height: 45.75pt; width: 153pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Abeona
Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>BLA
resubmission anticipated in second half of 2024</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Closed
$75 million underwritten offering in May, extending expected cash runway into 2026</I></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CLEVELAND,
May 15, 2024 &ndash; Abeona Therapeutics Inc. (Nasdaq: ABEO) today reported financial results for the first quarter of 2024 and recent
corporate progress.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;We
are grateful to our existing as well as new investors who have demonstrated their support through the recent financing, which has extended
our cash runway into 2026, well beyond anticipated regulatory milestones,&rdquo; said Vish Seshadri, Chief Executive Officer of Abeona.
&ldquo;We now remain focused on working with the FDA to address the CMC deficiencies noted in the CRL and making the BLA resubmission
to bring pz-cel to RDEB patients as soon as possible.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>First
Quarter and Recent Progress</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Corporate
highlights</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">On
                                            May 7, 2024, Abeona closed a $75 million underwritten securities offering with participation
                                            from both new and existing investors.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">In
                                            January 2024, Abeona entered into a $50 million credit facility and received the first tranche
                                            of $20 million.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Pz-cel
for RDEB</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">In
                                            April 2024, Abeona received a Complete Response Letter (CRL) from the U.S. Food and Drug
                                            Administration (FDA) regarding the Company&rsquo;s Biologics License Application (BLA) for
                                            </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">prademagene
                                            zamikeracel (<FONT STYLE="font-weight: normal">pz-cel) for recessive dystrophic epidermolysis
                                            bullosa (RDEB), based on the need for additional Chemistry Manufacturing and Controls (CMC)
                                            information. In the CRL, the FDA noted that certain additional information needed to satisfy
                                            CMC requirements must be resolved before the application can be approved. The information
                                            needed to satisfy the CMC requests in the CRL pertains to validation requirements for certain
                                            manufacturing and release testing methods. The CRL did not identify any deficiencies related
                                            to the clinical efficacy or clinical safety data in the BLA, and the FDA did not request
                                            any new clinical trials or clinical data to support the approval of pz-cel. The Company anticipates
                                            completing the BLA resubmission in the second half of 2024.</FONT></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">New
                                            pz-cel data will be presented at upcoming medical meetings. At the Society for Investigative
                                            Dermatology (SID) Annual Meeting, being held on May 15-18, 2024, new long-term safety data
                                            with up to 11 years of follow-up has been accepted as a late-breaking presentation.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>U.S.
commercial launch preparations for pz-cel</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abeona
                                            continues to advance key commercial activities in preparation for a potential U.S. launch
                                            for pz-cel, including onboarding discussions with epidermolysis bullosa treatment sites,
                                            conducting medical and payer engagement, as well as building supply chain and enterprise
                                            capabilities to support the Company&rsquo;s transition to a commercial stage company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>First
Quarter Financial Results and Cash Runway Guidance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash,
cash equivalents, restricted cash and short-term investments totaled $62.7 million as of March 31, 2024, compared to $52.6 million as
of December 31, 2023. Net cash used in operating activities was $14.5 million for the three months ended March 31, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abeona
estimates that its current cash and cash equivalents, restricted cash and short-term investments, as well as the credit facility, combined
with the net proceeds from the underwritten securities offering, are sufficient resources to fund operations into 2026, before accounting
for any potential revenue from commercial sales of pz-cel, if approved, or proceeds from the sale of a Priority Review Voucher or PRV,
if awarded by the FDA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development expenses for the three months ended March 31, 2024 were $7.2 million, compared to $8.0 million for the same period of
2023. General and administrative expenses were $7.1 million for the three months ended March 31, 2024, compared to $4.0 million for the
same period of 2023. Net loss was $31.6 million for the first quarter of 2024, or $1.16 loss per common share, including a change in
the fair value of warrant liabilities due to remeasurement of the Company&rsquo;s issued stock purchase warrants. Net loss in the first
quarter of 2023 was $9.1 million, or $0.54 loss per common share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Conference
Call Details</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will host a conference call and webcast on Wednesday, May 15, 2024, at 8:30 a.m. ET, to discuss the first quarter results. To
access the call, dial 888-506-0062 (U.S. toll-free) or 973-528-0011 (international) and Entry Code: 496484 five minutes prior to the
start of the call. A live, listen-only webcast and archived replay of the call can be accessed on the Investors &amp; Media section of
Abeona&rsquo;s website at <U>https://investors.abeonatherapeutics.com/events</U>. The archived webcast replay will be available for 30
days following the call.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Abeona Therapeutics </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abeona
Therapeutics Inc. is a clinical-stage biopharmaceutical company developing cell and gene therapies for serious diseases. Prademagene
zamikeracel (pz-cel) is Abeona&rsquo;s investigational autologous, COL7A1 gene-corrected epidermal sheets currently in development
for recessive dystrophic epidermolysis bullosa. The Company&rsquo;s fully integrated cell and gene therapy cGMP manufacturing facility
served as the manufacturing site for pz-cel used in its Phase 3 VIITAL&trade; trial, and is capable of supporting commercial production
of pz-cel upon FDA approval. The Company&rsquo;s development portfolio also features AAV-based gene therapies for ophthalmic diseases
with high unmet medical need. Abeona&rsquo;s novel, next-generation AAV capsids are being evaluated to improve tropism profiles for a
variety of devastating diseases. For more information, visit <U>www.abeonatherapeutics.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>This
press release contains certain statements that are forward-looking within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and that involve risks and uncertainties. We have attempted
to identify forward-looking statements by such terminology as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;believe,&rdquo; &ldquo;anticipate,&rdquo;
&ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;potential,&rdquo; and similar words and expressions (as well as other words or expressions
referencing future events, conditions or circumstances), which constitute and are intended to identify forward-looking statements. Actual
results may differ materially from those indicated by such forward-looking statements as a result of various important factors, numerous
risks and uncertainties, including but not limited to, the timing and results of ongoing testing and other corrective actions being performed
in response to the FDA&rsquo;s identified deficiencies, which could delay the Company&rsquo;s BLA resubmission; the timing and outcome
of the FDA&rsquo;s review of our resubmission; the FDA&rsquo;s grant of a Priority Review Voucher upon approval; continued interest in
our rare disease portfolio; our ability to enroll patients in clinical trials; the outcome of future meetings with the FDA or other regulatory
agencies, including those relating to preclinical programs; the ability to achieve or obtain necessary regulatory approvals; the impact
of any changes in the financial markets and global economic conditions; risks associated with data analysis and reporting; and other
risks disclosed in the Company&rsquo;s most recent Annual Report on Form 10-K and subsequent periodic reports filed with the Securities
and Exchange Commission. The Company undertakes no obligation to revise the forward-looking statements or to update them to reflect events
or circumstances occurring after the date of this press release, whether as a result of new information, future developments or otherwise,
except as required by the federal securities laws.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
and Media Contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Greg
Gin</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VP,
Investor Relations and Corporate Communications</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abeona
Therapeutics</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ir@abeonatherapeutics.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ABEONA
THERAPEUTICS INC. AND SUBSIDIARIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed
Consolidated Statements of Operations and Comprehensive Loss</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(In
thousands, except share and per share amounts)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0">For the three months</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">ended March 31,</P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Revenues:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">License and other revenues</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; width: 68%; text-align: left">Research and development</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">7,207</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">8,041</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">General and administrative</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">7,123</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,997</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">14,330</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">12,038</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Loss from operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(14,330</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(12,038</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Interest income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">843</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">364</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(952</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(101</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Change in fair value of warrant and derivative liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(17,301</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,265</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Other income</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">162</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">403</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Net loss</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(31,578</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(9,107</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Basic and diluted loss per common share</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(1.16</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.54</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Weighted average number of common shares outstanding &ndash; basic and diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">27,315,537</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">16,904,024</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Other comprehensive income (loss):</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Change in unrealized (losses) gains related to available-for-sale
    debt securities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(118</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">64</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Comprehensive loss</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(31,696</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(9,043</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ABEONA
THERAPEUTICS INC. AND SUBSIDIARIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed
Consolidated Balance Sheets</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(In
thousands, except share and per share amounts)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0">March 31,</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">2024</P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: center">ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current assets:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; width: 68%; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">17,558</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">14,473</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Short-term investments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">44,786</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">37,753</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Restricted cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">338</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">338</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Other receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,232</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,444</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Prepaid expenses and other current assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,811</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">729</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left">Total current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">66,725</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">55,737</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Property and equipment, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,767</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,533</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Operating lease right-of-use assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,222</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,455</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Other assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">114</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">277</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">74,828</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">64,002</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: center">LIABILITIES AND STOCKHOLDERS&rsquo; (DEFICIT) EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3,362</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,858</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Accrued expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,791</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,985</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Current portion of operating lease liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,044</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">998</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Current portion payable to licensor</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,691</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,580</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Other current liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left">Total current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,889</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,422</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Long-term operating lease liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,046</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,402</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Long-term debt</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,079</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Derivative liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,005</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Warrant liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">48,690</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">31,352</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left">Total liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">83,709</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49,176</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Commitments and contingencies</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Stockholders&rsquo; (deficit) equity:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">Preferred stock - $0.01 par value; authorized 2,000,000 shares; No shares issued and outstanding as
    of March 31, 2024 and December 31, 2023, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt">Common stock - $0.01 par value; authorized 200,000,000 shares; 27,550,693 and 26,523,878 shares issued
    and outstanding as of March 31, 2024 and December 31, 2023, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">276</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">265</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">772,129</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">764,151</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Accumulated deficit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(781,102</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(749,524</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Accumulated other comprehensive loss</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(184</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(66</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total stockholders&rsquo; (deficit) equity</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(8,881</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">14,826</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total liabilities and stockholders&rsquo; equity</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">74,828</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">64,002</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "U E@# 2(  A$! Q$!_\0
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MM]GNU>Z7GH:OP6_:BTKXKZTNB3:9-I&KLC21(9!+%*%&2 V!@@<X(]>:]SX
M&*^%OAI\:OA9\*=6DN- \)ZS?3L/+_M2_N$,^P]=JCY0#@<<9[U]>_#CXDZ-
M\4_#XU?1)G> .8I(I5VR1/U*L/7!!XR,$8-:X2O[2/)*:<EV_K\CJRK'K$4U
M3JU8SJ*^W;[DGZK0Z^BBBO1/H0HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:+V<4_1W7X.S]$>B?\%&M0FG^-.C6;$B"VT9&C7/&7DDW'ZG:!^ KY?MDPO
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M^M?19+@EB*SKU?@AJ[[76J^[=GR>?Y@\/16'I/WZFBMND]/Q>B^9[/\ L)?
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M2>*\C8]M--:#:/PH/'45ROQ!^)?AKX7:$VL>)]5ATJRSM1I"2TK?W44<L?8
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M]JU\Q)98MVZ1B?[S$X&>[#T-?KKI&DVFA:7:Z=80);6=I$L,$,8PJ(H 4#Z
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MP6^,5G9W<CV^F7UT-,U:TD)"J2VP.1V9&.<]<9'0U^JXSSD5^1?[3]FOA_\
M:+\<);_NQ_:/VD8[,RJY(_$DU]5DV(J8Z-7!XA\R:NKZVZ;_ #379H^+SS#4
M\!.ECL,N62E9VT3Z[;:V:?=,_78#(%!YK'\)WW]J>&M*O2<FYLX9B3ZL@/\
M6M@GK7QK5C[V,N9)GYO?\%!_B]>>(_B-%X'M+AET?18TDN(D/$UTZALMCKM4
MJ #T)8UZ-^S]^P3H$_AG3M=^(#7%_J-Y$LXTB*4Q0P*PRJN5(9FQ@D @ \<X
MS7RC\:-<BO/VC/%NHWPDFMH_$4IE5,%C''-M(&>,E4P,\5]F)_P4B\!<*OAS
M7PH&,;(.G_?ROOL12QE'!4:&!3LU=VWO9/?U?X'YIA:V"KXZOB,PDM':*>UD
MVKV\DOQ/:]/_ &8?A3IL:I#X"T7:O0R6XD/XELDUH_\ #/\ \-<_\B+H'_@O
MC_PKPE?^"D'@1O\ F7=?_P"^8/\ XY3'_P""DO@./_F6_$'_ 'Q!_P#'*^>>
M"S26KC)_-_YGU*Q^4+12C]W_  #VB_\ V8_A7J$;K/X$T7#<$Q6XC/X%<8_"
MOG+]H?\ 8:T71_"^H^)/ !N+2XL(VN)M'ED,L<L:C+>63E@P ) )(.,#!Q71
MG_@I3X#/_,M^(/\ OF#_ ..4RY_X*-> KVVEA?PUK[1R(592L'((P0?WE=.'
MI9OAYJ<5*RZ-W3756;./$ULEQ,'&4HIOJE9I]'=(\_\ V /C!>6/BJX\ WMP
MTVF7T3W-@KL3Y,RC<RKGH&7)P.ZY[FOOP@>E?DC^S=JOV#]H/P1/;YC2355B
M"^BR93'Y-7ZWC\JG/Z,:.+4HJW,KOUNU^AIPW7E6P;A-WY79/RLFOST\A&=4
M!). *_(K]HCXIZI\=_C%?W$+27-C'='3](LDS@1AMBD#IND/)/?<!T K]4OB
M5?OI7P^\37L?$EOIES*I]UB8C^5?E;^R/HD?B']H7P1!.-Z)=FZ((ZF.-G'Z
M@'\*Z<AC"E"OBI*[@M/N;?Y6]+G'Q).=6=#!Q=E-Z_>DOS/L/X-?L#>#_#VA
MVMWXWMV\1Z\Z!YK<S,EK QZHH0@MCU8\XX KV6W_ &9OA7;(H3P%H6 , M9J
MQQ[YSGZFO3STH.0?6OGZN.Q5:3E.H]>S:^Y+8^EHY=A,/%0ITUIW2;?JWN>:
MR?LU_"R5<-X!T#'7BR0?J!69J/[)OPBU)"LO@32H\C&;=6A/X%&%>N8(I2M9
M+%5XO2HU\W_F;O"8>2UIQ^Y?Y'YV?M6?L:6?PLT"7QAX,EN)=$@8?;M-N6,C
M6RL0!(C'DKD@$')&0<D9QT__  3Y^,UY)J5[\.]3N6FM#"U[I?F,28BO,D0)
MZ*0=X'08;UK[&^(VAP^)O 7B+2KA \-[I\\#*PZ[HV'Y]*_+7]DS5)='_:$\
M$,IPTEZ;9^>H=&4C]:^LPM6>9Y=6IUW=P5TWOLVOR:OO8^*QE".4YI0JX=6C
M4=FEMND_D[IV[H_7*F2?<;Z4^F2#Y&^E?%GZ S\6]!\6W?@3XG?V_8(KWNGW
M\TT"L,CS SA21WP2#COC%?9'P._82M?$&G1>*/BC=WM]JFHG[6VE)*4V[_F_
M?N/F9SG) ( Z')S7RK\(=%M_$7[1/AS3KI0]M-XA7S$89#*)BQ!^N,5^PQ/<
M\>U?=YYC:F&<*=%V;2NUO9;)/UNW8_-^'\!2Q?M*E=<RC+1/:[2NVNNEDNAY
M9IW[+GPGTN%8H/ >CLH[SP>:Q^I8DG\36A+^SQ\,94VMX"\/D?\ 7A&/Z5Z)
MNI<DU\6\16;NYO[V??+"8>*LJ:^Y?Y'A?C#]C'X3>++)XU\,1:-<$?)=:2[0
M.GN #M/T(-?GY\<?@[J_[.WQ'32FO7F@8"\TO5(LQLZAC@G!^5U(P0#Z$<$5
M^N@^\1C_ .O7Q3_P4OL81X<\"WVT>>E[<P;\<[&C4D9^JBOH<EQ]?ZS&A.3E
M&5U9ZVTO=7]+>:/E\^R[#K"2Q%.*C*-G=:7UM9V];^I] _LS?$N;XL?![0]<
MO2&U,*UK>L!C=-&2I;'^T,-_P*O5Z^6_^"=TID^!U\&.=NLS@#T_=Q&OJ3KW
MKP\;35'%5:<59)NQ]#EU65;"4JDG=M*YXY^UKXTNO ?P!\6:GI\K07KVZVL4
MR'#1F5UC+ ]B Q(/K7YY?LH?!&S^.WQ-_LC4[B6'1K&V-[>>2P#R*&"K&#VW
M,W)ZX!QSS7ZL^(M#TC7-*EM-;L;._P!-&))(;^)9(?EY#,&!'&,Y/3%?/6H_
MM-? #X1:K<IHJZ;_ &C@Q3-X:TQ?F (.TR*JJW..C$<5ZN78RK1P]2AA:;<Y
M=5K;M]VOWGC9I@J-;$T\1BJJ5./1Z7ZOKUTOOL>@:3^RA\)-&A6.'P+I<F !
MOND:9CCU+DULQ?L]_#.)=J> ] V^GV"/_"O$KK_@HY\.XC^XT;Q!<^_DQ)_.
M2J[_ /!2/P&HR?#?B#_OF#_XY6?U/-9ZN,G\W_F;K'9/'12@EY)?Y'MMQ^S=
M\+KS)D\!:%SUVV:K_+%>6?%G]A;P)XET&\D\*6+>&]=2,O;FWE9H)&'(1T8D
M 'IE<$9SSC!R[7_@I!\.9CB71?$$ [GR8F_E)7H7PW_;$^&?Q-U>'2K'5Y=.
MU.<A8;74X3 96/158_*2>PSD]LTN3-<+^\M)6UZM?/?0'4RC&+V5XMO39)_)
MV6I\.?LI^.]0^&OQTT6%F>"WO[K^R=0MV. =[;1D=,J^"#]1W-%4=;M5L/VH
M[^&+"JGC X"\8S=@_P!:*^AS#"4L7.%9NS<4?+9=F%; 4Y4(ZI2?^7_!/UCH
MHHKX(_30HHHH **** /"OVD_V=++XRZ&U_81I:^++2,_9;D\"=1_RQD/H><'
M^$GTR*_.34+&[TC4;FPOH'M;VVD:*:"489&!P01Z@@U^QN,U\5_MW_""&T^Q
M_$'3H0DCR+9ZFJ# ;(Q'*??C:3W^6O$Q^%4XNM%:K?T/B\^RR-2#Q=)6DMTN
MJ[^JZ]T?(T4A]:OVQ)QFLJ&0G'J16I;$8!KYF7<_-)Z%K:".:M6-LUW?6T"C
M<994C ]R0 /UJ!.E=7\+-*76OB7X5LB-RRZG;AEQ_"'!/Z TX1YY*/=I&E&'
MM*D8=VE][/=?^"C\R:9\,/ VE*-H;46( /01P;<>_P!\5^?\9(.#SBOM;_@I
MIK7F:_X&TD-_JK>YNV4'IN9%!Q_P$_D:^)U)R*_I+(HN. A?K=_BSV.(&I9A
M.W2R^Y+_ #-"U;<!6]9J"B\5SMFV&'89KHK)LHO'M7N3/"I'W]^P5\/;32O
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M)O\ @HK\4U/":!C_ *\6_P#CE?H/_P *;\!?]"7X?/\ W"X/_B:/^%-> ?\
MH2?#W_@K@_\ B:S_ +2R_P#Z!5]__ -?[*S/_H,?W/\ S/SU_P"'B_Q4)Y30
M/_ %O_CE>8?%WX^Z[\<-3T_4/$5KI:7UG&85N+"W,3NAY"OECD Y(],GUK]6
M1\&? /\ T)/A[_P5P?\ Q-!^#7@%@0?!/A[!'3^RX.G_ 'S6M+.,'0DJE/#6
M:ZIV?Y&-;(\=B(.%7%-I]&FU^9\$_L/_ !V'@#QW_P (OJEQLT'7I%12Y^6"
M[Z(WH P^4^^T]J_2<G\,5^2/[4GP9G^!GQ6N[*T5TT*_)O=+E&1B,G)C!_O(
MQQZXVGO7WI^Q]\<E^,_PRA6^G#^)='"VFH!C\TO!\N;W# 8)_O*WM1G6&A5A
M',*&L9)7]>_Z/S#(<7.A.>68C246[>:[+Y:KR/?#TK\E/VQB%_:9\;$]!/"?
M_($=?K7W%?DG^V0?^,E_&O\ UVB_]$1U'#?^]R_PO\T:\5/_ &.'^)?DS]4/
M!=PEYX1T6>,[HY+*%U/J"@(_G6V",5\P_L:?M#Z-XY^'FD^%=1U"&T\4:1"M
MI]GG<*;J)1B-X\_>PN 0,G(SC!%?3N,_6OG<30J8>M*E45FG]Z[KR9]+@\1#
M%4(U:;NFON?5>J'T445SG<,Q7Y(_M?N)/VD/'.T[O])1>/7R8QBOU%^(7Q&T
M#X8>'+G7/$.H0V-E I8"1P'E('"1KU9CT 'K7Y3:-::A^T+^T#&5@*S^(M9,
M\B*,^3"7W,3[+&#S[>]?7<.P<)U<1)6BHM7^Y_@EJ?#<3U%4ITL+!WFY)VZV
MLTOO;T/UD\!6[6O@G0(I!AX]/MU;ZB-<UT&.:C@B2")(XQM1%"JOH!T%2'H:
M^1>KN?;1CRQ43\=/B'I-LW[3.OZ;JBDV,OBJ2*X&XKF)[D[N1R,JW4=*^_Q^
MP5\'L8&BWV/^PE/_ /%5\A?MX?#N[\#?'>YUV&-H]/U]$OK>=00!.H"R+G^\
M" WT85]M?LV?M&Z!\:O!NG*=0@@\4P0K%?Z;(X67S%&"Z#^)&QD$9QG!Y%?:
MYC6Q#PE#$8>;4;6=F]'IO;S3/@<KP^&6-Q&%Q<$Y7NKI.ZN]K^JT7Z&*/V"O
MA !_R![X?]Q&;_XJF-^P1\'F.3HU]G_L(S__ !5?1>#1@U\S_:&,_P"?LOO?
M^9];_9F!_P"?,?N7^1\YC]@?X/?] :^!]M2G_P#BJ>/V"?@\.FC7X_[B4_\
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M:3Q$VO-GYD^!/V ?B1XFNXI/$/V/PO8,0999YA<3D=\(A()QZL*^^O@_\']
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M[L>%4<DGZ"OG>/\ :;\5>-KBZ;X?_#RZUW3(9#$-1N9_+C<CK@8 '8X+9YY
MJ:E6-.RD]7M9-O[D8U\52PS2J-W=[))MNV^B3=EW/I \<TH.1SQ7SC_PMCXZ
M%LCX6VVT^MTN?SWUJ^"/VB-8F\<6'A+QQX1G\+:GJ (M)O-WQRL,\=._0$$]
MLXS62Q-.ZW5^Z:_0P68T')1DI*[25XR2N]E=JVI[T:#035+5M5M]%TZZO[R0
M0VEM$TTLC=%11DD_0 UU7MJ>DVDM2V#D<TO)SQ7S5:_M.>,?'+R3^ _AM=ZK
MI:R&.._NYMBO@\G& !]-V1WJU%\6OC>K9F^%ENT?7"70!_\ 0S_*N3ZU3>J3
M:\D[?D>7',Z$E>',UW49-/T:5GZH^B5:BO)/A+\=1\0M<U#PYJ^A7/AKQ+81
MB66RG;>&3CE3@=,C@CH003V*Z85(SCS1>AVT:\<1!3I:K[OE9ZH]?HHHJSI"
MBBB@!N!7EG[1'Q;3X2?#R[U")U.L7?\ HNGQG&3*1R^/11R?P'>O4\@YKP#X
MQ_L[7_QC^*6CZCJ>K)%X2L;8(UE&3YSR;B7 [ ,-H+9R , =".>O[3V;5-7;
MT]//Y'GXZ5>-!K#*\WHO*_7Y(^?_ -F?]G>X^*^K-XJ\3I*_AY)C(!+G=J$N
M23R>=@.=Q[G(!ZX^][2TBLK:*""-888U")%&N%11T '8 <5#I.DVFAZ;;V%C
M;I:V=M&(HH(QA44<  >E7B*C#8>.'A9:M[ONS'+LOIY?2Y(ZR>K?5O\ R[!T
MKRS]IO45TOX$>,)20/,LS ,]R[*F/UKU+'-?-?[=GB<:9\+=/T='Q-JM\H*C
MO'&-QX_WME5B9*%&4GV9IF-54<)5F^B?WM67XL^<OV2? Y\9?&/3)9$W6FDJ
MVH2D]-R\1_CO(/X&OTA4 YKYK_8@^'W_  C_ ,/+KQ%<Q;;O6YLQ%AR($)"_
MFVX_3%?2H[\USX"E[.@K[O7_ "_ \[(,-]7P47):RU?SV_ =4%Q;I<PO%*@D
MC=2K*PR&!&""._!-3T5Z)]%N?CE^TK\)3\&?C'K>@Q1E-+D?[9IS'I]GD)*J
M#WVG<A_W:^M_^"91SX0\=?\ 7_;<?]LVJ_\ \%&OA?\ V]\/]+\:6D.^[T*;
MR+EE'/V:4@9/LK[?H&)K+_X)D2$^&_'D9' O+5L_6-_\*^YKXGZWDSDWJFD_
M5-+\4TS\ZPV$^I9ZH)633:]&G^3NEY'VW1117PQ^C'RW^TC^Q3HOQ3-QK_A8
MP:!XK8%I%"[;:]/_ $T ^ZY_O@<]P>M<K^R%XZ\??#OQ4/A)X]T'4HH45VTR
M]DB9XX H+&/S0"K1'!*G/!XZ$ ?91R,\_CB@=\_E7IK,*DL.\-67-'I?=/HT
M_P!.VFAXKRNG'$K%T&X2ZI;27FN_G^9)1117F'M"#C-?,W[/G_)P_P 7Q_T\
MJ?\ Q]J^F2<5\S_L^QNG[1'Q>9D95-P""00#\[=#WKCK?Q*?K^C/)Q?^\8?_
M !/_ -)9],T445V'K'RS^V1J$NE^+/A=>6]H]]/;ZD\J6T1P\S*\1"#@\G&!
MQU-=(?VD/&?3_A37B(_]M?\ ["L?]J^-W^(?P?949U76.2H) _>0]<5]+XS7
MF1A.5:HXR:U6UNR[GS=.C5J8S$.%5Q5X[)._NKNF> C]HWQD>!\&O$/XS?\
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M^)K='Z6,O_Q--_9.T.SN/@5X>DN;*%Y<SY,D0W?ZU^M>P_\ "/:8?^8?:_\
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M(@0N<,<D[CD\?2BBNRE5FL/4IIZ-H\NO2@\91J->\E+7Y'T71117&>H%%%%
M!1110 5"((XV+*BACU(')HHH$R:BBB@9"\*2$;D5B.A89Q4U%% D%1+"D9)5
M%4MU(&,_6BB@&2U#+"DP =%<#LPS110#&?8K?_GA'_WP*7[#!_SQB_[X%%%!
M)*B!% 4  #@"GT44%D,<"(S%556/4@8S]:FHHH$B%XTG4!T5AZ,,U*!@8HHH
M$ALD2RKM<!E/4$9H2-8U 4!1Z 8HHH*'TQT$JX8 @]01110 D<:QIA0%'H!B
ME9!(N& ((Y!HHH $B6)-J*%4= !BGT44 %%%% $4D"3* ZJPSG##-1_8K?\
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#1__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>abeo-20240515.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWamPGbP9z5Z8eekhvWB0bQl67y8mwTSSAiu8vf8WgYUJ -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:ABEO="http://abeonatherapeutics.com/20240515" elementFormDefault="qualified" targetNamespace="http://abeonatherapeutics.com/20240515">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://abeonatherapeutics.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="abeo-20240515_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="abeo-20240515_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>abeo-20240515_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>abeo-20240515_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://abeonatherapeutics.com/role/Cover" xlink:href="abeo-20240515.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://abeonatherapeutics.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm139653180825008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 15, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 15,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-15771<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ABEONA
THERAPEUTICS INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000318306<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">83-0221517<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6555
Carnegie Ave<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">4th Floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cleveland<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">OH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">44103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">646<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">813-4701<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ABEO<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M;=#5^[?P_<"H-'_SG2L#[]'YYHHS> CL"7!\H90Y#NS+=/%?2/]?4$L#!!0
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M8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ T#NO6)E<G",0!@  G"<  !,
M             ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M" #0.Z]8JVODLUX$   7$0  &               @($."   >&PO=V]R:W-H
M965T<R]S:&5E=#$N>&UL4$L! A0#%     @ T#NO6)^@&_"Q @  X@P   T
M             ( !H@P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #0.Z]8
MEXJ[',     3 @  "P              @ %^#P  7W)E;',O+G)E;'-02P$"
M% ,4    " #0.Z]8JL0B%C,!   B @  #P              @ %G$   >&PO
M=V]R:V)O;VLN>&UL4$L! A0#%     @ T#NO6"0>FZ*M    ^ $  !H
M         ( !QQ$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#
M%     @ T#NO6&60>9(9 0  SP,  !,              ( !K!(  %M#;VYT
D96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  ]A,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.1.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://abeonatherapeutics.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>abeo-20240515.xsd</File>
    <File>abeo-20240515_lab.xml</File>
    <File>abeo-20240515_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "ABEO",
   "nsuri": "http://abeonatherapeutics.com/20240515",
   "dts": {
    "schema": {
     "local": [
      "abeo-20240515.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "abeo-20240515_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "abeo-20240515_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://abeonatherapeutics.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-05-15",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-05-15",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001493152-24-019449-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-24-019449-xbrl.zip
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M/R'YY]-WXS&Z2@B-S] 7'HWG[(%_CV[PAIRAGP@C F=<?(^^8;I56_A50HE
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MSPT".E>]W&E3][A5%$3O=SDS22BUJ"EVC,6"TR1*LH2M?Y$GGR+!ME;91*Z
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M3O525*\ K=0S8F45Z'=5"<IKL?U^>7W3M?PD-^M-\J\53HG<\E]02P,$%
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M  !E>#DY+3$N:'1M4$L! A0#%     @ T#NO6*S\32(0$P  6),   L
M         ( !-S   &9O<FTX+6LN:'1M4$L%!@     %  4 -@$  '!#
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="abeo-20240515.xsd" xlink:type="simple"/>
    <context id="AsOf2024-05-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000318306</identifier>
        </entity>
        <period>
            <startDate>2024-05-15</startDate>
            <endDate>2024-05-15</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-05-15" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-05-15" id="Fact000004">0000318306</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-05-15" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-05-15" id="Fact000010">2024-05-15</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-05-15" id="Fact000011">ABEONA THERAPEUTICS INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-05-15" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2024-05-15" id="Fact000013">001-15771</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-05-15" id="Fact000014">83-0221517</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-05-15" id="Fact000015">6555 Carnegie Ave</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2024-05-15" id="Fact000016">4th Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-05-15" id="Fact000017">Cleveland</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-05-15" id="Fact000018">OH</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-05-15" id="Fact000019">44103</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-05-15" id="Fact000020">646</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-05-15" id="Fact000021">813-4701</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-05-15" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-05-15" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-05-15" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-05-15" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2024-05-15" id="Fact000026">Common     Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2024-05-15" id="Fact000027">ABEO</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2024-05-15" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-05-15" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
